BIIB vs QCLS · P/E 21, rev $9.89B vs rev $46.7K
Biogen Inc (BIIB) versus Q/C Technologies, Inc. (QCLS) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ. It is led by Christopher A. Viehbacher.
Q/C Technologies, Inc. (QCLS) is a computer hardware company listed on NASDAQ.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported QCLS revenue for 2026-06-30 was $46.7K. Net income was -$7.9M. QCLS currently screens at market cap $30.7M.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. QCLS currently screens at market cap $30.7M.
Not investment advice. Open the BIIB and QCLS stock pages for the full models.
Not investment advice.